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Abstract
Poly(ADP-ribosyl)ation (PARylation) is a posttranslational protein modification catalyzed by
members of the poly(ADP-ribose) polymerase (PARP) enzyme family. PARylation regu-
lates a wide variety of biological processes in most eukaryotic cells including energy
metabolism and cell death, maintenance of genomic stability, chromatin structure and tran-
scription. Inside the nucleus, cross-talk between PARylation and other epigenetic modifica-
tions, such as DNA and histone methylation, was already described. In the present work,
using PJ34 or ABT888 to inhibit PARP activity or over-expressing poly(ADP-ribose) glyco-
hydrolase (PARG), we show decrease of global histone H3 and H4 acetylation. This effect
is accompanied by a reduction of the steady state mRNA level of p300, Pcaf, and Tnfα, but
not of Dnmt1. Chromatin immunoprecipitation (ChIP) analyses, performed at the level of the
Transcription Start Site (TSS) of these four genes, reveal that changes in histone acetyla-
tion are specific for each promoter. Finally, we demonstrate an increase of global deacety-
lase activity in nuclear extracts from cells treated with PJ34, whereas global
acetyltransferase activity is not affected, suggesting a role for PARP in the inhibition of his-
tone deacetylases. Taken together, these results show an important link between PARyla-
tion and histone acetylation regulated transcription.
Introduction
PARylation is a posttranslational protein modification catalyzed by enzymes belonging to the
PARP family. PARPs use NAD+ as substrate and, upon cleaving off nicotinamide, they cova-
lently transfer the ADP-ribosyl moiety to suitable acceptor proteins and, subsequently, elon-
gate the chain by adding further ADP-ribose units. In this way, they are capable to modify the
protein activity by creating a branched polymer, termed poly(ADP-ribose) (PAR), which can
be rapidly degraded by PARG and by ADP-ribosylhydrolase 3 (ARH3) [1,2]. Free or protein-
bound ADP-ribose polymers work as signal transducers by binding other proteins through
their conserved PAR recognition modules, including PAR-binding motifs (PBMs), PAR-bind-
ing zinc finger (PBZF) domains, and macrodomains [3].
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The founding member of the PARP family is PARP-1, also known as ADP-ribosyltransfer-
ase Diphtheria toxin-like 1 (ARTD1, [4]), a ubiquitous and abundant nuclear protein. PARP-1
catalyzes the covalent attachment of ADP-ribose polymers on itself and other acceptor pro-
teins, including histones, DNA repair proteins, transcription factors, and chromatin modula-
tors [5]. Initially studied in the context of DNA damage detection and repair [6,7], PARP-1 has
more recently been linked to the regulation of chromatin structure and transcription [8–10].
As a structural chromatin protein, enzymatically silent PARP-1 inhibits transcription by con-
tributing to the condensation of chromatin. However, once activated by environmental stimuli
and developmental signals, PARP-1 can modify itself and other chromatin-associated proteins,
thereby loosening chromatin to facilitate gene transcription [11].
The varied roles of PARP-1 in gene regulation were recently extensively reviewed [10]. Mul-
tiple mechanisms were shown to be involved. Chromatin loosening by PARP at Drosophila
puff loci was initially observed [12]. Subsequently, PARylation of the nucleosome-remodelling
ATPase ISWI was shown to inhibit its binding and chromatin condensation activity at heat
shock-loci in Drosophila [13], while in human cells the same modification directed recruitment
and activation of ALC1, a member of the SNF2 ATPase superfamily [14]. Recently, direct
remodelling of nucleosomes due to histone PARylation was demonstrated [15] as well as regu-
lation of PARP-1-dependent gene expression through promoter-directed recruitment of a
nuclear NAD+ Synthase [16].
More importantly, cross-talk between PARP-induced modifications and other epigenetic
marks was reported. Regulation of the expression and activity of the DNA methyltransferase
DNMT1 by PARP-1 affected genomic DNA methylation [17,18]. PARylation of KDM5B, a
histone lysine demethylase acting on trimethyl H3 lysine 4 (H3K4me3), was shown to block
the binding and demethylase activity of this enzyme [19].
The link between PARP and histone acetylation, however, has received less attention. Using
PJ34 or ABT888 to inhibit PARP enzymatic activity or over-expressing PARG, we observed a
decrease of global histone H3 and H4 acetylation, and this effect was accompanied by a reduc-
tion in the steady state mRNA level of p300, Pcaf, and Tnfα, but not of Dnmt1. The pattern of
histone H3 and H4 acetylation changes was specific for each promoter, as shown by ChIP anal-
yses. By assaying nuclear extracts from cells treated with PJ34 for global HAT or HDAC activ-
ity, we found a regulatory role of PARylation in the inhibition of deacetylase function.
Materials and Methods
Cell culture and treatments
NIH3T3 mouse fibroblasts were maintained as sub-confluent culture in high-glucose Dulbec-
co's modified Eagle's medium, supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
50 units/ml penicillin and 50 mg/ml streptomycin.
PARP inhibition was obtained by adding to the medium PJ34, 5 μM final concentration, or
ABT888, 0.5 μM final concentration, for 30 min, 1 h or 3 h.
Transfection of cells and PARG over-expression
0.5×106 cells were seeded in 60×15 mm culture dishes (Greiner bio-one) and transfected with
Lipofectamine Plus reagent (Invitrogen) adopting the manufacturer's protocol. Assays were
performed with 4 μg/dish of purified plasmid DNA of either empty vector (pCS2) as a control
or Myc–PARG construct (pCS2-Myc-PARG) or Myc–catalytically mutated PARG construct
(pCS2-Myc–PARG_E757N) [20] together with 0.4 μg/dish of pBabe-puro (Addgene) vector
for puromycin selection of transfected cells. After 24 hours cells were collected and whole cell
extracts were prepared.
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Western blot analysis
Whole cell extracts. Trypsinised and phosphate-buffered saline (PBS)-washed cells were
collected by centrifugation and lysed in RIPA buffer (50 mM Tris–HCl pH 8, 150 mMNaCl,
0.5% sodium deoxycholate, 0.1% SDS, 1% Nonidet P-40, 1 mM EDTA), supplemented with
protease inhibitors (complete EDTA-free, Roche Applied Science). Protein concentration was
determined using the Bradford protein assay reagent (Bio-Rad) with bovine serum albumin
(Promega) as standard. Equal protein amounts (50 μg) were subjected to 15% or 8% SDS–
PAGE and transferred to PVDF 0.2 μm (Bio-Rad) or Hybond-ECL nitrocellulose (GE Health-
care) membranes, respectively.
Nuclear extracts. Cells were washed twice with Phosphate-buffered saline (PBS), collected
by centrifugation and treated for 30 min on ice with a nuclei specific buffer (10 mM Tris–HCl
pH 7.9, 4 mMMgCl2, 1 mM EDTA, 0.5 mM DTT, 0.25 M sucrose, 1% Triton X-100),supple-
mented with protease inhibitors (complete EDTA-free, Roche Applied Science). Nuclei were
collected by centrifugation at 10.000 xg at 4°C for 10 min. Pellets were lysed in RIPA bufferand
processed as above.
HAT and HDAC activity were assayed using EpiQuickTM kits (Epigentek), according to
manufacturer instructions.
Antibodies. Primary antibodies used were: mouse monoclonal anti-PAR (Trevi-
gen,4335-MC-100), mouse monoclonal anti-Myc (9E10 clone, hybridoma-conditioned
medium), rat monoclonal anti-α tubulin (Santa Cruz Biotechnology, sc-53030), rabbit poly-
clonal anti-acetyl-histone H3, recognizing histone H3 acetylated at the N-terminus (Millipore,
06–599), rabbit polyclonal anti-acetyl-histone H4, recognizing all 4 lysine residues (Millipore,
06–866), rabbit polyclonal anti-histone H3, recognizing the C-terminal region of histone H3,
(Millipore, 07–690), rabbit polyclonal anti-histone H4, recognizing the C-terminal region of
histone H4 (Abcam, ab10158). Secondary antibodies used were: goat anti-mouse, anti-rabbit
and anti-rat horseradish peroxidase-conjugated (Santa Cruz Biotechnology).
Detection was carried out using the ECLWestern blotting detection reagents (GE Health-
care). Densitometric analysis was performed using Image Lab software (Bio-Rad). For each
lane, the value corresponding to the area of histone H3 or H4 band in the membrane probed
with anti-acetyl-histone H3 or H4 was normalized by dividing for the value corresponding to
the area of histone H3 or H4 band in the same membrane re-probed, after mild stripping, with
anti-C-terminal region of histone H3 or H4.
qRT-PCR
Total RNA was purified by RNeasy mini kit (Qiagen). Concentration, purity and integrity of
preparations were evaluatedspectrophotometrically, followed by agarose gel-ethidium bromide
electrophoresis. Total RNA (1 μg) was subjected to retrotranscription using Bioscript Reverse
Transcriptase (Bioline) and random hexamer mix. Amplification of cDNA was performed in
triplicate for each sample, using SsoAdvanced SYBR Green supermix on a MiniOpticon Real-
time PCR System (Bio-Rad). The values, obtained by three independent experiments, were
normalized with Actβ and Hprt. PCR efficiency was 90–100% for each set of primers. Primers
used were as follows:
Actβ Fw: CTTGGGTATGGAATCCTGTGGCAT;
Actβ Rev: GCTCAGGAGGAGCAATGATCTTGA;
Dnmt1 Fw: GAGGACAACAAGCACAAGTTCTGC;
Dnmt1 Rev: TGGGTATTCTCAGGCCTGTAG;
Hprt Fw: GTCAACGGGGGACATAAAAGT;
Hprt Rev: CAAAGTCTGGCCTGTATCCAA;
p300 Fw: AGCGGCCTAAACTCTCATCTC;
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p300 Rev: GGCTGCATCTTGTACTATGCC;
Pcaf Fw: TGGCCAAGATGTTTCTGAACC;
Pcaf Rev: TTCCAAGAGCTGTCGTCTCAT;
Tnfα Fw: CCCCAAAGGGATGAGAAGTT;
Tnfα Rev: TGGGCTACAGGCTTGTCACT;
Chromatin immunoprecipitation (ChIP)
ChIP analyses were performed on chromatin extracts using MAGnify Chromatin Immunopre-
cipitation System kit (Invitrogen), according to manufacturer's specifications. Cell cultures
(about 1×106 cells/ml) were cross-linked, in standard culture dishes, at room temperature for
10 min by formaldehyde 37% (final concentration 1%). Reaction was stopped by 5 min incuba-
tion in 0.125 M Glycine. Cell monolayer was harvested by scraping in ice-cold PBS containing
protease inhibitors. After cell lysis (final concentration of cell: 106 cells/50 μl) chromatin was
sonicated using Bioruptor NextGen (Diagenode) to High Power, 18 cycles for 30 seconds ON,
30 seconds OFF. Average size of sonicated DNA was around 400 bp, as measured by agarose
gel electrophoresis. Aliquots containing 200.000 cells were snap-freezed and stored at -80°C.
Sheared chromatin was immunoprecipitated with anti-acetyl-Histone H3 or anti-acetyl-His-
tone H4, or rabbit IgG as negative control. DNA amplification was performed using SsoAd-
vanced SYBR Green supermix on a MiniOpticon Real-time PCR System (Bio-Rad).
The Ct values for each gene promoter, obtained from three biological replicates of samples
analysed in triplicate, were normalized with an internal region of Actβ and INPUT DNA, as
follows: first, the Ct value of the immunoprecipitated (IP) target gene was corrected subtracting
the Ct value of the Actβ IP; then, the Ct value of the target gene INPUT was corrected subtract-
ing the Ct value of the Actβ INPUT; finally, the normalized target gene IP value was corrected
subtracting the normalized INPUT value.
Primers used were as follows:
Actβ Fw: AAGCATCCTTAGCTTGGTGAG, Rev: ACAAGATGGTGAATGGTGAG (spanning
region from +2666 to + 2769)
Dnmt1 A1 Fw: TATAGCCAGGAGGTGTGGGTG, Rev: AACGAGACCCCGGCTTTTT (spanning
region from -2 to +160);
Dnmt1 A2 Fw: TCCTCTGCAAGAGCAGCACTA, Rev: ATGTACCACACAGGGCAAGA (spanning
region from -100 to +93);
p300 Fw: AGCTCAGTGTGGCCATTAGG, Rev: TGTCCTCCTCCTTCTCATCG (spanning region
from -183 to +13);
Pcaf Fw: ACGCCATGATTTTGGTGAAT, Rev: GAGACCCAACTTCCTCCACC (spanning region
from -107 to +110);
Tnfα Fw: GTTTTCCGAGGGTTGAATGAG, Rev: TCTGTTCTCCCTCCTGGCTA (spanning
region from -79 to +54).
A map describing the position of the promoter fragments analysed for each target gene is
presented in S2 Fig.
Statistical analysis
Statistical analysis was carried out by the Student's t-test. Differences were considered signifi-
cant when p0.05.
Results
Global decrease of histone H3 and H4 acetylation level following PARP
inhibition
To determine the influence of PARP activity on the global histone acetylation level, we initially
analysed by western blot the extent of both histones H3 and H4 lysine acetylation in conditions
Poly(ADP-Ribosyl)ation and Histone Acetylation
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in which PARP enzymes are inhibited by PJ34. Mouse NIH3T3 cells were treated with PJ34 for
30 min, 1 hand 3 h. Whole cell extracts were prepared, and aliquots were run on SDS-PAGE
gels, transferred to a membrane and probed with antibodies recognizing acetylated lysines of
histone H3 and H4 tails. The results are shown in Fig 1, panels A and B for H3 and H4, respec-
tively. Following inhibition of PARPs activity with PJ34, we observed a decrease of lysine acety-
lation in both histone H3 and H4 tails, within 3 h treatment. As a control for reduced level of
ADP-ribose polymers, we utilised on the same cell extracts an antibody against PAR (Fig 1,
panel C). In order to exclude a non specific effect of the drug utilized to inhibit PARPs, we
repeated the same experiment with the inhibitor ABT888, and the results are shown in Fig 1,
panels D and E for H3 and H4, respectively. PARPs inhibition by ABT888, as shown by
decreased PAR levels (Fig 1, panel F), leads to decreased H3 and H4 acetylation. Taken
together, the results obtained with the two different inhibitors underline the true involvement
of PARP activity rather than reflecting the effect of the drug utilized.
Moreover, the decrease of histone H3 and H4 acetylation level, following PARP inhibition,
was not a peculiarity of NIH3T3 cells, because it was observed also in another mouse fibroblast
cell line, L929, as well as in the neuroblastoma cell type N2a (see S4 Fig).
PARG over-expression induces global decrease of histone H3 and H4
acetylation
To investigate the molecular mechanism underlying the global decrease of histone tail acetyla-
tion, observed in condition of inhibited PARP activity, we sought to analyse whether the same
effect can be observed by reducing PAR through a different approach. In order to deplete the
cells of PAR, we ectopically over-expressed the PARG enzyme. Whole cells extracts were
prepared after transfection with the empty vector pCS2 or with Myc-PARG constructs, one
over-expressing PARG and one containing a catalytically mutated PARG. We checked for
Fig 1. PJ34- and ABT888-induced reduction of PARs influences histone H3 and H4 acetylation. (A)
Representative Western blot of whole cell extracts from cells treated with the inhibitor PJ34 (5μM) at the
indicated times relative to untreated cells (NT, value ~1), run on a 15% SDS-PAGE, and probed with anti-
acetyl-histone H3 and anti-C-terminal of H3 antibodies to measure the relative level of H3 acetylation. Error
bars indicate the standard deviation of data obtained from three independent experiments. (B) Same as in (A)
but hybridisation was performed with anti-acetyl-histone H4 and anti-C-terminal of H4 antibodies to measure
the relative level of H4 acetylation. (C) The same extracts used in panels A and B were run on an 8%
SDS-PAGE and probed with anti-PAR antibody to visualize ADP-ribose polymers level. (D) Same as in (A)
but from cells treated with the inhibitor ABT888 (0.5 μM). (E) Same as in (D) but hybridisation was performed
with anti-acetyl-histone H4 and anti-C-terminal of H4 antibodies to measure the relative level of H4
acetylation. (F) The same extracts used in panels D and E were run on an 8% SDS-PAGE and probed with
anti-PAR antibody to visualize PARs level. *p 0.05; **p 0.01; ***p 0.001
doi:10.1371/journal.pone.0144287.g001
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exogenous protein expression by western blotting, as reported in Fig 2, panel A. Panel B shows
that in cells containing plasmid pCS2-Myc-PARG no anti-PAR signal is visible, while the usual
smear of PAR is present in cells containing the empty vector. In the extracts from cells contain-
ing plasmid pCS2-Myc-PARG, we observed reduced level of histone H3 and H4 tails acetyla-
tion (panel C and D, respectively), relative to the control. Interestingly, in the extracts from
cells transfected with the plasmid containing catalytically mutated PARG, pCS2-Myc-PAR-
G_E757N [20], decreased levels of histone H3 and H4 acetylation were observed (panel C
and D, respectively), even though these cells are characterized by a greater amount of PAR
(panel B).
In summary, the observed decrease of lysine acetylation, for both histone H3 and H4, is due
to an unbalance in the level of PAR (see Discussion).
PARP inhibition down-regulates p300 and Pcaf expression by
decreasing promoter histone H3 and H4 acetylation
In order to investigate the link between histone acetylation and PARP activity, we next ana-
lysed the mRNA steady state level of the genes coding for two relevant enzymes responsible for
the maintenance of histone acetylation, namely p300 and Pcaf by qRT-PCR analysis. As shown
in Fig 3A, significant down-regulation of both genes was detected after 1 h of treatment with
PJ34. However, the transcriptional effect observed at 1 h did not lead to decreased protein
amount up to 3 h (S1 Fig), suggesting that the global H3 and H4 acetylation decrease reported
was not due to reduced amount of p300 and PCAF. Rather, reduced acetyltransferase activity
or increased deacetylase activity could have been involved.
Fig 2. Ectopic over-expression of PARG influences histone acetylation levels. (A) Representative
Western blot of total proteins from cells transfected with empty vector (pCS2) or Myc–catalytically mutated
PARG construct (pCS2-Myc-PARG_E757N) or Myc–PARG construct (pCS2-Myc-PARG) run on an 8%
SDS-PAGE, and probed with anti-Myc epitope to check for exogenous protein expression. (B) Same as in (A)
but hybridisation was performed with anti-PAR antibody to visualize PARs level, and with anti-α Tubulin as
protein loading control. (C) The same extracts used in panel A were run on a 15% SDS-PAGE, and probed
with anti-acetyl-histone H3 and anti-C-terminal of H3 antibodies. Histograms indicate acetylation level of cells
transfected with pCS2-Myc-PARG construct (black), or with pCS2-Myc-PARG_E757N (grey) relative to
control cells transfected with empty vector (white, value ~1). Error bars indicate the standard deviation of data
obtained from three independent experiments. (D) As in (C), but using anti-acetyl-histone H4 and anti-C-
terminal of H4 antibodies to measure the relative level of H4 acetylation. *p 0.05; **p 0.01; ***p 0.001
doi:10.1371/journal.pone.0144287.g002
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We hypothesized that hypoacetylation in the chromatin region spanning the TSS was
responsible for decreased p300 and PcafmRNA accumulation. Therefore, we investigated by
ChIP the promoter region of p300 and Pcaf genes, by using the same antibodies utilized in the
western blot experiments, and the results are shown in Fig 3B. Acetylation of both histone H3
and H4 significantly decreased following 1 h of PARP inhibition.
We conclude that PARP activity promotes p300 and Pcaf transcription by maintaining the
correct level of histone H3 and H4 acetylation at their TSS.
PARP inhibition leads to decreased histone H3 but not histone H4
acetylation at the Dnmt1 promoter
In order to better investigate the relationship between promoter acetylation and PARP activity
we tested by ChIP assay the Dnmt1 gene, coding for DNAmethyltransferase 1, because the
expression and the activity of this enzyme are known to be regulated by PARP-1 [17,21]. Since
it was previously shown that the Dnmt1 promoter is occupied by poly(ADP-ribosyl)ated
PARP-1, and that the decrease of PAR leads to aberrant methylation of the CpG island close to
the TSS [22], we searched for the possible involvement of histone acetylation.
After PJ34 treatment for 1 h, a decrease of histone H3 acetylation at the Dnmt1 promoter
region spanning the TSS was observed, while histone H4 acetylation was slightly increased.
This pattern of histone tails acetylation changes did not affect Dnmt1 transcription (Fig 4).
PARP inhibition down-regulates basal Tnfα transcription
We then investigated if the mRNA accumulation of other genes known to be PARP-1-depen-
dent was affected by PARP inhibition. In particular, we tested the Tnfα promoter, known to be
involved in the inflammatory response to antigenic stimuli, and whose activation was shown to
Fig 3. Inhibition of PARP activity affects transcription and promoter histone acetylation level of p300
and PCAF. (A) Real time qRT-PCR analysis of mRNA accumulation for two acetyltransferases, p300 and
Pcaf. Histograms indicate mRNA level of cells treated with PJ34 for 1 h (black), relative to untreated cells
(grey, value ~1). Values were normalized with Actβ or Hprt. (B) Real time qRT-PCR analysis of histone H3
and H4 acetylation of p300 and Pcaf promoter regions. Histograms indicate acetylation level of cells treated
with PJ34 for 1 h (black), relative to untreated cells (grey, value ~1). Values were normalized with an internal
region of Actβ. Primers used were described in Materials and Methods. Error bars indicate the standard
deviation of data obtained from three independent experiments. NT: control cells, no treatment. *p 0.05;
**p 0.01.
doi:10.1371/journal.pone.0144287.g003
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be impaired in PARP-1 knockout mice [23]. Cells were treated with PJ34 for 1 h, and the results
are shown in Fig 5A: Tnfα basal transcription was affected by PARP inhibition, as indicated by
significant decrease of mRNA accumulation. When the TSS region of the Tnfα promoter was
investigated by ChIP after PARP inhibition for 1h, using antibodies against histone H3 or H4
acetylation, a slight but significant increase in histone acetylation levels was observed (see Fig
5B), suggesting that, in this case, PARylation is regulating transcription through a mechanism
other than acetylation of H3 or H4 (see Discussion).
PARP inhibition up-regulates global HDAC activity
In order to gain a better insight on the molecular mechanism responsible for the observed
effects, we tested nuclear extracts from NIH3T3 cells, treated with PJ34 for 1h, for global acetyl-
transferase or deacetylase activity, and the results are shown in Fig 6. Global deacetylase activity
was found to increase upon PARPs inhibition (panel B), whereas acetyltransferase activity did
not change when tested in the same conditions (panel A). Panel C shows the decrease of his-
tone H3 and H4 acetylation in the same nuclear extracts, as expected.
These data suggest that in normal conditions PARP activity is required to prevent default
histone deacetylation, thus allowing maintenance of constitutive transcription.
Discussion
Eukaryotic gene regulation occurs at many steps during the process of gene expression: chro-
matin structure is one of the key control step. External stimuli are capable of modifying the epi-
genetic code associated with a specific promoter to allow for transcription and cell adaptation.
This concept is easily demonstrated in simple organisms such as yeast where the availability of
mutants allows the association of specific chromatin patterns to defined phenotypes under dif-
ferent environmental conditions. In more complex systems, depletion of proteins involved in
Fig 4. Inhibition of PARP activity does not affect transcription ofDnmt1, but influences its promoter
acetylation level. (A) Real time qRT-PCR analysis of mRNA accumulation for Dnmt1. Histogram indicates
mRNA level of cells treated with PJ34 for 1 h (black), relative to untreated cells (grey, value ~1). Values were
normalized with Actβ. (B) Real time qRT-PCR analysis of histone H3 and H4 acetylation of two Dnmt1
promoter regions. Histograms indicate acetylation level ofcells treated with PJ34 for 1 h (black), relative to
untreated cells (grey, value ~1). Values were normalized with an internal region of Actβ. Primers A1 and A2
were described in Materials and Methods. Error bars indicate the standard deviation of data obtained from
three independent experiments. NT: control cells, no treatment. *p 0.05; **p 0.01.
doi:10.1371/journal.pone.0144287.g004
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epigenetic control, as well as the use of drugs capable of altering their activity are becoming
increasingly useful: in addition to provide evidence of changes at the level of the specific mark,
they could also shed light on the possible interplay among epigenetic marks [24–27].
Cross-talk between PARylation and other epigenetic marks was reported. Regulation of the
activity of the DNAmethyltransferase DNMT1 by PARP-1 affected genomic DNA methyla-
tion [17,18]. PARylation of KDM5B, a histone lysine demethylase acting on trimethyl H3
lysine 4 (H3K4me3), was shown to prevent the binding and demethylase activity of this
enzyme [19]. The connection between PARP activity and histone acetylation, however, has
Fig 5. PARP inhibition down-regulates constitutive Tnfα transcription. (A) Real time qRT-PCR analysis
of mRNA accumulation for Tnfα. Histogram indicates mRNA level of cells treated with PJ34 for 1 h (black),
relative to untreated cells (grey, value ~1). Values were normalized with Actβ. (B) Real time qRT-PCR
analysis of histone H3 and H4 acetylation of Tnfα promoter region. Histograms indicate acetylation level of
cells treated with PJ34 for 1 h (black), relative to untreated cells (grey, value ~1). Values were normalized
with an internal region of Actβ. Error bars indicate the standard deviation of data obtained from three
independent experiments. NT: control cells, no treatment. *p 0.05.
doi:10.1371/journal.pone.0144287.g005
Fig 6. PARP inhibition up-regulates global HDAC activity. (A) Nuclear extracts from NIH3T3 cells, treated
with the inhibitor PJ34 (5 μM) for 1 h, and assayed for global HAT activity. Histograms indicate colorimetric
quantification, through an ELISA-like reaction, of HAT activity in treated cells relative to untreated (NT, value
~1). Error bars indicate the standard deviation of data obtained from three independent experiments. (B)
Same as in (A) but the assay was for global HDAC activity. *p 0.05. (C) The same nuclear extracts as in (A)
and (B) were run on a 15% SDS-PAGE, and probed with anti-acetyl-histone H3 and anti-C-terminal of H3
antibodies to measure the relative level of H3 acetylation. Error bars indicate the standard deviation of data
obtained from three independent experiments. (D) Same as in (C) but hybridisation was performed with anti-
acetyl-histone H4 and anti-C-terminal of H4 antibodies to measure the relative level of H4 acetylation.
doi:10.1371/journal.pone.0144287.g006
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received less attention. Earlier in vitro reports suggested a correlation between the two post-
translational modification processes [28,29], while subsequent evidence points to a competi-
tion between them [30,31]. In cultured cortical neurons histone H4 acetylation was shown to
be affected by PARP-1 activation [32]. More recently, an interplay between histone acetyla-
tion/deacetylation and poly(ADP-ribosyl)ation was shown [33–34]. In order to investigate the
interdependence between PARylation and histone tail acetylation, we studied the effect of
PARP inhibition both on global histone acetylation level and at specific promoters. We chose
to utilize antibodies recognizing all acetylated lysines at the same time on either H3 or H4,
instead of antibodies against single lysines, to get a general idea about the hypothesized correla-
tion. We show that the global levels of histone H3 and H4 acetylation decrease as a conse-
quence of alteration of PARP function by two different strategies: i) using PJ34 or ABT888 to
inhibit PARP enzymatic activity (Fig 1); ii) over-expressing PARG to deplete the cell of ADP-
ribose polymers (Fig 2). Moreover, we utilised a third experimental strategy, i.e., over-expres-
sion of a catalytically mutated PARG, to analyse the effect of increasing the amount of PARs
relative to a normal condition, and we show that even in this case histone H3 and H4 acetyla-
tion decreases. Since we found that inhibition of PARylation caused an increase in global
HDAC activity (Fig 6), we suggest that PARs reduction, due to PARP inhibitors or PARG
over-expression lead to failed inhibition of HDACs, thus explaining histone acetylation
decrease. To explain why the same effect is observed also in the presence of higher amount of
PARs, present in cells transfected with the catalytically mutated PARG, we hypothesize that
excess PARylation modifies PARP-1, causing it to be released from chromatin [35]. Presum-
ably, chromatin bound PARP-1 is required to interact with remodelling factors on gene pro-
moters and to recruit/regulate epigenetic marks. Thus, poly(ADP-ribose) levels that are either
too high or too low lead to the same outcome in terms of global histone acetylation state: they
both cause widespread histone hypoacetylation. These results underscore the critical impor-
tance of keeping balanced PAR levels, as already argued relatively to the cross-talk between
poly(ADP-ribosyl)ation and DNAmethylation [18]. When we used an alternative strategy to
increase ADP-ribose polymers level, i.e., by over-expressing the architectural protein CTCF
(CCCTC-binding factor), which strongly stimulates PARP-1 activity [36], we again observed
global decrease of H3 acetylation (S5 Fig). In addition, we analysed extracts of cells treated with
the PARG inhibitor gallotannin, and found a transient increase of histone H3 and H4 acetyla-
tion at 30 min, followed by a decrease within 3 h of treatment (S6 Fig). The transient increase
observed was possibly due to inhibition of global HDAC activity by increased PARs.
It has been shown that PARP-1 and PARG are localized at the promoters of positively and
negatively regulated target genes, where they act in concert to control the amount of PARs [8].
Based on the results obtained by assaying HAT and HDAC activity upon PARP inhibition (Fig
6), we hypothesize that, in normal conditions, ADP-ribose polymers regulate histone lysine
acetylation and transcription by inhibiting the function of deacetylases. PARP-1 was indeed
described in complex with HDACs 1–3, but not HDACs 4–6, to inhibit their function [37].
Other nuclear PARPs could be implicated as well: PARP-14 was shown to interact with
HDAC2 and HDAC3 [38]. We cannot exclude that, in defined conditions, ADP-ribose poly-
mers could affect also the function of acetyltransferases. For example, PARP-1 was found in
complex with p300 [39], suggesting a stimulatory effect on this enzyme.
Besides global effects, we described alteration of specific regulatory patterns at the level of
defined promoters, as follows: i) PJ34-induced PARP inhibition leads to decreased acetylation
at both histone H3 and H4 around the TSS region of p300 and Pcaf promoters (Fig 3B), and
this effect correlates with decreased mRNA accumulation: histone tails acetylation is, in fact,
responsible for keeping promoter nucleosomes accessible ([40] and ref therein); ii) in the case
of the Dnmt1 promoter, only H3 acetylation decreases, while histone H4 acetylation is slightly
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increased (Fig 4): this pattern of modifications does not parallel transcriptional down-regula-
tion, suggesting a compensatory role for H4 over H3 acetylation, as proposed in the case of S.
cerevisiae Adr1-regulated genes [41]; iii) Tnfα constitutive transcription is affected by PARP
inhibition, as indicated by significant decrease of basal mRNA accumulation after PJ34 treat-
ment (Fig 5A). When the TSS region of the Tnfα promoter is investigated by ChIP in non-
inducing conditions, a slight but significant increase of histone H3 and H4 acetylation is
observed (Fig 5B), suggesting that, in this specific case, PARylation is likely regulating tran-
scription through a mechanism other than acetylation of H3 or H4. For example, PARylation
of histones could be implicated [31,42–44]: since the acceptor sites for this modification are
lysine residues, the possibility exists that PJ34 induced PAR reduction allows for the observed
acetylation increase. An alternative explanation can be provided when considering that histone
acetylation was found to be in continuous dynamic turnover [45,46]. When this turnover was
inhibited, the expression of certain genes was no longer possible, despite the increase of histone
acetylation levels at their promoters [45,46]. This indicates that cycles of histone acetylation
and deacetylation are important for induction of certain genes in mammalian cells.
We argue that for each promoter different patterns of interactions between PARPs and his-
tone acetyltransferases/deacetylases and chromatin remodelers occur.
Taken together, our results indicate that PARP activity affects transcription by modulating
histone H3 and H4 acetylation at the level of specific promoters in a context-dependent man-
ner, thus underlying gene- and cell type-specific effects in determining PARP-dependent out-
comes, as already suggested [8,10].
The data presented in this work could help to address future investigations aimed at identi-
fying the specific targets of PARP activity among the enzymes regulating histone acetylation, in
particular deacetylases. In addition, it will be important to identify the specificity of acetyla-
tion/deacetylation sites and how are they regulated.
Supporting Information
S1 Fig. Analysis of acetyltransferase protein level.Western blot analysis of p300 (A) and
PCAF (B) in extracts from cells treated with PJ34 for 3 h relative to untreated cells (NT). Histo-
grams indicate p300 and PCAF protein level, normalized with α tubulin, from cells treated
with PJ34 for 3 h (black) relative to untreated cells (NT, grey). Antibodies used were: mouse
monoclonal anti-KAT3B/p300 CT (Millipore, 05–257), rabbit polyclonal anti-KAT2B/PCAF
(abcam, ab12188), and rat monoclonal antibody anti-α tubulin (Santa Cruz Biotechnology, sc-
53030).
(TIF)
S2 Fig. Map of the promoter fragments used in ChIP assays. For each gene the TSS (Tran-
scriptional Start Site) and the ATG are indicated.
(TIF)
S3 Fig. Analysis of PARG expression. (A) qRT-PCR of PargmRNA level from NIH3T3 cells
treated with PJ34 for the indicated times, relative to untreated cells. The mRNA values were
normalised to the mean expression of two housekeeping genes, Gusb and Hprt1. Taqman
probes were: Mm00449466_m1 for Parg, Mm00446956_m1 for Gusb, and Mm00446968_m1
for Hprt1. qRT-PCR conditions were as described in Ciccarone et al., Plos One 2008. Error
bars indicate the standard deviation of data obtained from three independent experiments. (B)
Western blot of whole cell extracts from the same cells as in (A) run on an 8% SDS-PAGE, and
probed with anti-PARG (Santa Cruz sc-21480), or anti-PAR, or anti-Tubulin antibodies.
(TIF)
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S4 Fig. Analysis of global histone acetylation level in L929 and N2a cells. (A) Western blot
of whole cell extracts from L929 cells treated with the inhibitor PJ34 (5 M) for 3 h relative to
untreated cells (NT, value ~1), run on a 15% SDS-PAGE, probed with anti-acetyl-histone H3
or anti-C-terminal of H3 antibodies to measure the relative level of H3 acetylation. Error bars
indicate the standard deviation of data obtained from the three independent experiments. (B)
Same as in (A) but hybridisation was performed with anti-acetyl-histone H4 or anti-C-terminal
of H4 antibodies to measure the relative level of H4 acetylation. (C) The same extracts used in
panels A and B were run on an 8% SDS-PAGE and probed with anti-PAR antibody to visualize
ADP-ribose polymers level. Panels D, E and F: same as in A, B and C, respectively but the anal-
ysis was done with whole cell extracts from neuroblastoma N2a cells.
(TIF)
S5 Fig. Analysis of global histone H3 acetylation level upon CTCF overexpression. (A)
Western blot of total proteins from cells transfected with empty vector (pCI) or His-tagged
recombinant CTCF (pCI-CTCF-His, Guastafierro et al., J. Biol. Chem 2008) run on an 8%
SDS-PAGE, and probed with anti-PAR antibody. (B) Same as in (A) but hybridisation was per-
formed with anti-His antibody to visualize CTCF, and with anti-Lamin B1, as protein loading
control. (C) The same extracts used in panel A and B were run on a 15% SDS-PAGE, and
probed with anti-acetyl-histone H3 and anti-C-terminal of H3 antibodies.
(TIF)
S6 Fig. Analysis of global histone acetylation level in the presence of gallotannin. (A) West-
ern blot of whole cell extracts from NIH 3T3 cells treated with the PARG inhibitor gallotannin
(Tannic Acid, Sigma) (30 M) for the indicated times relative to untreated cells (NT) run on an
8% SDS-PAGE, and probed with anti-PAR antibody to visualize ADP-ribose polymers. (B)
The same extracts as in (A) were run on a 15% SDS-PAGE and probed with anti-acetyl-histone
H3 or anti-C-terminal of H3 antibodies to measure the relative level of H3 acetylation. (C)
Same as in (B) but hybridisation was performed with anti-acetyl-histone H4 or anti-C-terminal
of H4 antibodies to measure the relative level of H4 acetylation.
(TIF)
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